Drug Side Effects
Search
PERSISTENT GENERALISED LYMPHADENOPATHY
PERSISTENT GENERALISED LYMPHADENOPATHY
was reported 25 times
PERSISTENT GENERALISED LYMPHADENOPATHY is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Anthelmintic [EPC]
1
0.0003
1
Oxytocic [EPC]
1
0.0003
2
CD30-directed Immunoconjugate [EPC]
3
0.0003
3
Antiparasitic [EPC]
1
0.0002
4
Pediculicide [EPC]
1
0.0002
5
Protease Inhibitor [EPC]
2
0.0000
6
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
7
Topoisomerase Inhibitor [EPC]
3
0.0000
8
Cytochrome P450 3A Inhibitor [EPC]
2
0.0000
9
Glycopeptide Antibacterial [EPC]
2
0.0000
10
Tetracycline-class Drug [EPC]
2
0.0000
11
Fluoroquinolone Antibacterial [EPC]
3
0.0000
12
Alkylating Drug [EPC]
5
0.0000
13
Macrolide Antimicrobial [EPC]
1
0.0000
14
Xanthine Oxidase Inhibitor [EPC]
3
0.0000
15
Nucleoside Metabolic Inhibitor [EPC]
3
0.0000
16
Interferon beta [EPC]
2
0.0000
17
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
1
0.0000
18
Aromatase Inhibitor [EPC]
1
0.0000
19
Histamine-2 Receptor Antagonist [EPC]
1
0.0000
20
Azole Antifungal [EPC]
1
0.0000
21
Microtubule Inhibitor [EPC]
1
0.0000
22
Expectorant [EPC]
1
0.0000
23
Corticosteroid [EPC]
5
0.0000
24
Kinase Inhibitor [EPC]
1
0.0000
25
Proton Pump Inhibitor [EPC]
1
0.0000
26
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000